Music Therapy for Parkinson's Disease and Lewy Body Dementia
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to test whether a music therapy intervention (MT) prevents hospital-acquired delirium (HaD) in patients with Parkinson's disease (PD) and Dementia with Lewy Bodies (DLB). Delirium is defined as a mental state in which you are confused, disoriented, and not able to think or remember clearly. It can start suddenly and is usually temporary. It is common among patients with PD/DLB during hospitalization.We are conducting a randomized controlled feasibility pilot study of music therapy (MT) in patients with PD/DLB in the inpatient acute hospital setting.We are testing if receiving music therapy lowers the risk of delirium, compared to other interventions. We are also testing if music therapy lowers the need for certain restraints and medications during the hospitalization.Participants admitted to UMass Memorial Medical Center will be invited to participate. Participants will be asked to undergo a music therapy intervention for 30 minutes 3 times per week, and to listen to personalized music playlists for 60 minutes 4 times per week. Participants will be assessed for HaD every 24 hours, and will undergo additional surveys and questionnaires.Researchers will compare the music therapy intervention to two another comparison groups: one group assigned to listen to music on their own, and one group assigned to receive only standard treatments. About one-third of the participants will be assigned to each of the three study groups.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it mentions that participants with carbidopa/levodopa on their medication list are eligible, suggesting you may continue taking these medications.
Is music therapy safe for humans?
How is music therapy different from other treatments for Parkinson's disease and Lewy Body Dementia?
Music therapy is unique because it uses rhythmic auditory cues and musical activities to improve motor and emotional functions, helping patients with Parkinson's disease and Lewy Body Dementia become more sociable and reduce symptoms. Unlike traditional drug treatments, it focuses on engaging patients through music to enhance their quality of life and social interactions.26789
What data supports the effectiveness of the treatment Music Therapy Intervention for Parkinson's Disease and Lewy Body Dementia?
Research shows that music-based movement therapy can improve motor function in Parkinson's disease patients, and music therapy can enhance social and emotional well-being in individuals with dementia. These findings suggest that music therapy may be beneficial for both motor and emotional symptoms in these conditions.2381011
Are You a Good Fit for This Trial?
This trial is for inpatients at UMass Memorial Medical Center with Parkinson's Disease or Dementia with Lewy Bodies. Candidates must be able to hear and enjoy music, not have a history of music-induced seizures, and should not be sedated in intensive care or expected to leave the hospital within 24 hours.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive music therapy intervention or control interventions during hospitalization
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Music Therapy Intervention
- Non-guided Music Listening
- Standard of Care
Music Therapy Intervention is already approved in China, United States for the following indications:
- Anxiety reduction in pregnant women
- Pain relief during labor
- Stress reduction in high-risk pregnancies
- Antepartum-related distress alleviation
- Improved caregiver-infant bonding
- Physiological stress reduction in infants post-partum
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Massachusetts, Worcester
Lead Sponsor